WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹114 Cr | ₹89 Cr | ₹69 Cr | ₹63 Cr | ₹34 Cr |
What is the latest Sundry Debtors ratio of WANBURY ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹114 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹63 Cr |
| Mar2021 | ₹34 Cr |
How is Sundry Debtors of WANBURY Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹114 Cr | 28.61 | |
| Mar2024 | ₹89 Cr | 28.68 | |
| Mar2023 | ₹69 Cr | 9.84 | |
| Mar2022 | ₹63 Cr | 82.20 | |
| Mar2021 | ₹34 Cr | - | |
Compare Sundry Debtors of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹918.4 Cr | 3.5% | 3.4% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 3.5% |
3.4% |
15.4% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses